Ozeroff Christopher David
S.V.P., General Counsel at ORKA
- Sold, on record
- $16k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Apr 4, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ORKAOruka Therapeutics, Inc.S.V.P., General Counsel
Sales by reason
0
Routine
6
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Apr 4, 2017Plan not stated
Sold 2.3% of their holdings
$1k418 shares at $2.41
- Feb 28, 2017Plan not stated
Sold 2.5% of their holdings
$1k465 shares at $2.61
- Sep 20, 2016Plan not stated
Sold 6.1% of their holdings
$3k1,185 shares at $2.89
- Apr 5, 2016Plan not stated
Sold 1.8% of their holdings
$1k366 shares at $3.52
- Mar 1, 2016Plan not stated
Sold 2.2% of their holdings
$2k458 shares at $3.51
- Sep 18, 2015Plan not stated
Sold 5.2% of their holdings
$7k1,129 shares at $6.32
6 of 6
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2017 | Apr 5, 2017 | ORKA | S.V.P., General Counsel | Form 4 sale | 418 | $1k | 2.3% | Plan not stated | SEC |
| Feb 28, 2017 | Mar 1, 2017 | ORKA | S.V.P., General Counsel | Form 4 sale | 465 | $1k | 2.5% | Plan not stated | SEC |
| Sep 20, 2016 | Sep 21, 2016 | ORKA | S.V.P., General Counsel | Form 4 sale | 1,185 | $3k | 6.1% | Plan not stated | SEC |
| Apr 5, 2016 | Apr 6, 2016 | ORKA | S.V.P., General Counsel | Form 4 sale | 366 | $1k | 1.8% | Plan not stated | SEC |
| Mar 1, 2016 | Mar 2, 2016 | ORKA | S.V.P., General Counsel | Form 4 sale | 458 | $2k | 2.2% | Plan not stated | SEC |
| Sep 18, 2015 | Sep 21, 2015 | ORKA | S.V.P., General Counsel | Form 4 sale | 1,129 | $7k | 5.2% | Plan not stated | SEC |